Enterocolitis Drug Development 2018 - Pipeline Analysis - ResearchAndMarkets.com

DUBLIN--()--The "2018 Enterocolitis Drug Development- Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.

Around 10 companies and universities are focusing on developing treatment options for Enterocolitis.

To assist investigators and funding and regulatory organizations, the publisher has come up with a comprehensive report on the Enterocolitis pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Enterocolitis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Enterocolitis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Key Topics Covered:

1 Enterocolitis Pipeline Analysis

2 Enterocolitis - Company Wise Pipeline Analysis

3 Enterocolitis R&D Pipeline Snapshots

4 Recent Developments in Enterocolitis Pipeline

5 Appendix

Companies Featured

  • Cancer Advances Inc
  • CJ HealthCare
  • Daewoong Pharmaceutical Co
  • Effexus Pharmaceutical
  • Eisai Co Ltd
  • Il-Yang Pharm.Co.,Ltd
  • Ironwood Pharmaceuticals
  • Jeil Pharmaceutical Co Ltd
  • Jiangsu Aosaikang Pharmaceutical
  • Mitsubishi Pharma Corporation
  • New Haven Pharmaceuticals
  • Pfizer
  • RaQualia Pharma Inc
  • Renexxion LLC
  • Rottapharm
  • Takeda Pharmaceutical Co
  • Trio Medicines Ltd
  • Yooyoung Pharm Co Ltd
  • Yuyu Pharma Inc

For more information about this report visit https://www.researchandmarkets.com/research/kjs5pt/enterocolitis?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Gastrointestinal Drugs